Effect of immunohistochemistry (IHC) - Equivocal breast carcinomas on performance of chromogenic in situ hybridization (CISH) and inter-site reproducibility

被引：0
|
作者：
Gong, Y.
Sweet, W.
Duh, Y. J.
Greenfield, L.
Trivedi, S.
Symmans, W. F.
Isola, J.
Sneige, N.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Invitrogen Corp, Camarillo, CA USA
[3] StatServ Consulting Inc, Chino Hills, CA USA
[4] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland
来源：
MODERN PATHOLOGY | 2008年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
139
引用
收藏
页码：33A / 33A
页数：1
相关论文
共 37 条
  • [1] Effect of immunohistochemistry (IHC)-equivocal breast carcinomas on performance of chromogenic in situ hybridization (CISH) and inter-site reproducibility
    Gong, Y.
    Sweet, W.
    Duh, Y. J.
    Greenfield, L.
    Trivedi, S.
    Symmans, W. F.
    Isola, J.
    Sneige, N.
    LABORATORY INVESTIGATION, 2008, 88 : 33A - 33A
  • [2] EGFR status in pediatric ependymomas using immunohistochemistry (IHC) and chromogenic in situ hybridization (CISH)
    Quezado, Martha
    Santi, Mariarita
    Rushing, Elisabeth
    Begnami, Maria
    VIRCHOWS ARCHIV, 2007, 451 (02) : 237 - 238
  • [3] HER2 amplification: Correlation of chromogenic in situ hybridization (CISH) with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH)
    Wixom, CR
    Albers, EA
    Weidner, N
    LABORATORY INVESTIGATION, 2003, 83 (01) : 51A - 51A
  • [4] Assessment of epidermal growth factor receptor (EGFR) by immunohistochemistry and chromogenic in situ hybridization (CISH) in metaplastic carcinomas of the breast
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 207 - 208
  • [5] Correlation of Her2/Neu testing using chromogenic in situ hybridization (CISH) with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) in breast cancer
    Hanna, WM
    Kwok, K
    LABORATORY INVESTIGATION, 2005, 85 : 35A - 35A
  • [6] Correlation of Her2/neu testing using chromogenic in situ hybridization (CISH) with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) in breast cancer
    Hanna, WM
    Kwok, K
    MODERN PATHOLOGY, 2005, 18 : 35A - 35A
  • [7] Prospective Testing for Her2 Using Simultaneous Immunohistochemistry (IHC) and Chromogenic In Situ Hybridization (CISH)
    De Luca-Johnson, Javier
    Bryant, Britni R. E.
    Mitchell, Jeannette
    Cortright, Valerie
    Weaver, Donald L.
    Goodwin, Andrew
    Harmon, Maureen
    Ambaye, Abiy
    MODERN PATHOLOGY, 2017, 30 : 505A - 505A
  • [8] Prospective Testing for Her2 Using Simultaneous Immunohistochemistry (IHC) and Chromogenic In Situ Hybridization (CISH)
    De Luca-Johnson, Javier
    Bryant, Britni R. E.
    Mitchell, Jeannette
    Cortright, Valerie
    Weaver, Donald L.
    Goodwin, Andrew
    Harmon, Maureen
    Ambaye, Abiy
    LABORATORY INVESTIGATION, 2017, 97 : 505A - 505A
  • [9] Chromogenic in situ hybridization (CISH) to detect HER2 gene amplification in breast and gastric cancer: Comparison with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH)
    Kiyose, Shinichiro
    Igarashi, Hisaki
    Nagura, Kiyoko
    Kamo, Takaharu
    Kawane, Kazunori
    Mori, Hiroki
    Ozawa, Takachika
    Maeda, Matsuyoshi
    Konno, Keisuke
    Hoshino, Hideaki
    Konno, Hiroyuki
    Ogura, Hiroyuki
    Shinmura, Kazuya
    Hattori, Naohiko
    Sugimura, Haruhiko
    PATHOLOGY INTERNATIONAL, 2012, 62 (11) : 728 - 734
  • [10] Human Papillomavirus (HPV) Detection by Chromogenic In Situ Hybridization (CISH) and p16 Immunohistochemistry (IHC) in Breast Intraductal Papilloma and Breast Carcinoma
    Guo, Hua
    Idrovo, Juan P.
    Cao, Jin
    Roychoudhury, Sudarshana
    Navale, Pooja
    Auguste, Louis J.
    Bhuiya, Tawfiqul
    Sheikh-Fayyaz, Silvat
    CLINICAL BREAST CANCER, 2021, 21 (06) : E638 - E646
1234